Another SH here, looking at valuation to peers:
For VHT, current MC is $350M. With CARR of $19.9M.
But considering the $70M they have in cash, rather than looking at their MC/Rev if we take EV/Sales we get a multiple of 16.5 for VHT.
IME on the otherhand, has EV/Sales of just 4. And using comparative metrics above, the MC of IME is around $43M, with CARR of $8.8M. And with 20% growth projected with FY rev of $10-12M.
From current prices of 3.6c for IME, we should really be at 10-12c range if the market values us to the peer VHT! Given we are 1/4 of the EV/Sales ratio as one way of comparing between the two companies.
Another comparison we could make, to a much bigger company is PME. PME is however profitable and NPAT is $23M. But in time IME will be too.
MC is $2.88B, with Annual Rev only $56.8M. Looking at their EV/Sales: 47.9. Which is about 3X what VHT is and 12X what IME is.
If the market valued IME to the same EV/Sales as PME, in time when we grow in revenue to cover the costs and become profitable, we would see IME trading at 10-12X current prices.
Of course, the market will do what it does but it's nice to know it is valuing peers at significantly higher prices which shows the upside case scenarios. And this is not even factoring the 20% growth in IME's revenue projected.
Please DYOR.
- Forums
- ASX - By Stock
- ImexHS Valuation
Another SH here, looking at valuation to peers:For VHT, current...
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IME (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 37163 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 7500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 37163 | 0.500 |
1 | 23194 | 0.450 |
1 | 6252 | 0.405 |
1 | 1250 | 0.400 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 7500 | 1 |
0.560 | 10 | 1 |
0.570 | 4996 | 1 |
0.605 | 12727 | 1 |
0.660 | 335 | 1 |
Last trade - 16.12pm 06/05/2024 (20 minute delay) ? |
Featured News
IME (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online